Search

Search Constraints

You searched for: Author/Creator Sagalova, O.

Search Results

1. Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks. (March 2023)

2. Efficacy of bulevirtide as monotherapy for chronic hepatitis D (CHD): Week 48 results from an integrated analysis. (March 2023)

3. Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 2. (January 2015)

4. Strategies to manage hepatitis C virus (HCV) infection disease burden – volume 2. (January 2015)

5. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm – volume 2. (January 2015)